Results 81 to 90 of about 773 (166)
Acute Encephalitic Syndrome Induced by Scleromyxedema
Dermato-neuro syndrome is a potentially fatal neurological complication of scleromyxedema consisting of fever, seizures, and coma. This is an overlooked scleromyxedema case of a 62-year-old female patient from 2-years ago.
Magira, E.E. +7 more
core
Dermato-neuro syndrome in a case of scleromyxedema
Scleromyxedema is an uncommon connective tissue disease characterized by mucin deposits, fibrosis, and proliferation of fibroblasts in the dermis. Although it shares similar sclerodermoid features, it is a different clinical entity than scleroderma.
Sevgi Akarsu +3 more
core +1 more source
Wprowadzenie: Scleromyxedema jest przewlekłą chorobą zaliczaną domucynoz. Kryteria jej rozpoznania to: charakterystyczne twardzinopodobnezmiany skórne, gammopatia monoklonalna bez współistniejącychzaburzeń funkcji tarczycy, awbadaniu histopatologicznym ...
Jadwiga Dwilewicz-Trojaczek +6 more
doaj
JEADV Clinical Practice, Volume 3, Issue 4, Page 1294-1297, September 2024.
Emily R. Gordon +7 more
wiley +1 more source
Scleromyxedema was observed in a 43 year old male.The lesions were shiny, waxy-looking, soft,, papules, 2 to 4 mm in diameter and were most marked on the neck and ear lobules. There was no evidence of paraproteinemia.
A K, Bajaj +3 more
openaire +1 more source
Ultrastructural changes in scleromyxedema
Skin biopsy specimens from a 60-year-old patient with paraproteinemia and generalized changes of the skin typical of scleromyxedema were studied with the electron microscope. The dermis was dominated by collagen fibrils and accumulations of peculiar connective tissue cells, while elastic tissue was sparse and in some areas completely absent.
L, Danielsen, T, Kobayasi
openaire +2 more sources
Suspected cardiac toxicity to intravenous immunoglobulin used for treatment of scleromyxedema
Scleromyxedema is a rare, generalized form of lichen myxedematosus, which may be associated with systemic involvement and can be fatal. The therapeutic options available provide partial or inconsistent response and are associated with significant adverse
Binitha, M.P. +5 more
core +2 more sources
Combination Oral Prednisone and Intravenous Immunoglobulin in the Treatment of Scleromyxedema
Background: Scleromyxedema is a clinical variant of the rare disease papular mucinosis that has both cutaneous and systemic manifestations. Treatment options are numerous and tend to be associated with serious potential side effects and frequent relapse.
Marlene Dytoc +4 more
core +1 more source
Treatment of scleromyxedema Arndt-Gottron with a novel intravenous immunoglobulin preparation
Dear Editor, Scleromyxedema is known as a rare, severe mucinosis with characteristic waxy skin papules along with sclerodermiform induration of the skin and rare systemic manifestations. Monoclonal gammopathy of undetermined significance (MGUS; mostly
Niklas Negele +2 more
doaj +1 more source
Scleromyxedema: A rare case report
Scleromyxedema (SM), or Arndt–Gottron disease, is a rare variant of lichen myxedematosus commonly associated with monoclonal gammopathy and may involve multiple organ systems.
Talluru Vani +3 more
doaj +1 more source

